Dava Pharmaceuticals to Pay U.S. $11 Million to Settle False Claims Act Allegations

Dava Pharmaceuticals Inc. has agreed to pay the United States $11 million to settle allegations that it violated the False Claims Act by misreporting drug prices in order to reduce its Medicaid Drug Rebate obligations, the Justice Department announced today.